GME
GameStop Corp.
GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SCI
Service Corporation International
SCI has the edge over GME overall, supported by lower modeled downside and stronger modeled upside.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
SCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
SCI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over SCI in the historical PE scenario, which offers more potential upside but is not a forecast.
SCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $60.18 | -20% |
| Forward | 18x | $74.97 | — |
| Current | 19x | $74.97 | — |
| Fair | 20x | $80.86 | +7.9% |
| Expensive | 22x | $88.36 | +18% |
Historical ranges are pointers, not guarantees.
SCI's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
SCI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
SCI has the edge over GME on the outlook, with more favorable valuation and earnings expectations.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over SCI on earnings, with more consistent year-over-year improvement.
SCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.22 | +4.8% |
| Q3 2026 | $4.03 | +9.2% |
| Q2 2026 | $3.83 | +4.4% |
| Q1 2026 | $3.79 | +4.7% |
| Q4 2025 | $3.80 | +7.6% |
| Q3 2025 | $3.69 | +7% |
| Q2 2025 | $3.67 | +6.7% |
| Q1 2025 | $3.62 | +3.7% |
| Q4 2024 | $3.53 | 0% |
SCI earned $4.03 per share over the past year, up 9.2% from the year before.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
SCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +4.6% |
| Q2 2026 | $1.1B | +3.6% |
| Q1 2026 | $1.1B | +2.1% |
| Q4 2025 | $1.1B | +1.7% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.1B | +3% |
| Q1 2025 | $1.1B | +2.8% |
| Q4 2024 | $1.1B | +3.5% |
SCI has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.4 points |
| Q2 2026 | 21% | -0.1 points |
| Q1 2026 | 22% | -1.2 points |
| Q4 2025 | 25% | +0.8 points |
| Q3 2025 | 21% | +0.4 points |
| Q2 2025 | 21% | -0.3 points |
| Q1 2025 | 23% | +1.2 points |
| Q4 2024 | 24% | +1.1 points |
SCI has the edge over GME on profitability, with a higher operating margin.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over SCI on cash flow, with more consistent year-over-year improvement.
SCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $197.4M | +31% |
| Q2 2026 | $142.9M | +71% |
| Q1 2026 | $253.9M | +9% |
| Q4 2025 | $87.2M | -43% |
| Q3 2025 | $150.7M | -7.5% |
| Q2 2025 | $83.4M | -17% |
| Q1 2025 | $233M | +66% |
| Q4 2024 | $151.8M | -17% |
SCI's free cash flow has been positive every quarter for six years: $681M over the past year, up 10% from the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
SCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.1M shares |
| 1 year | -3% | -4.2M shares |
| 3 years | -9.9% | -15.1M shares |
| 5 years | -19% | -32.8M shares |
| Available history | -26% | -48.3M shares |
SCI has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $52.6M |
| Q2 2026 | $123.2M |
| Q1 2026 | $143.2M |
| Q4 2025 | $58.9M |
| Q3 2025 | $78.1M |
| Q2 2025 | $193.6M |
| Q1 2025 | $130.5M |
| Q4 2024 | $56.2M |
SCI spent $378M buying back its own shares over the past year, down 18% from the year before.
GME Net Leverage
SCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 4.0x | High |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.0x | Elevated |
SCI's net debt is about 4.0 years of its operating earnings (EBITDA), about the same as a year ago.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
SCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.2 | Neutral |
| Stochastic | 31.6 | Neutral |
SCI's weekly RSI is 43 (neutral) and its Stochastic is 32 (neutral).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME has the edge over SCI on valuation relative to its sector.
SCI PE vs Consumer Cyclical Sector
| Metric | SCI | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 3.2% above |
| PE % | 34 | 47 | 13 pts below |
SCI is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over SCI on trend strength, trading above more of its moving averages.
SCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $77.7 | 3.5% below |
| 20 week MA | $80.2 | 6.5% below |
| 50 week MA | $79.7 | 5.9% below |
| 100 week MA | $79.5 | 5.7% below |
| 200 week MA | $74.6 | 0.5% above |
SCI has fallen below most of its moving averages, though it's still 0.5% above its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over SCI on returns for 2026, with the stronger performance.
SCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $48.7 | +5.6% |
| 2021 | $48.7 | $69.7 | +43% |
| 2022 | $69.7 | $70.2 | +0.8% |
| 2023 | $70.2 | $68.5 | -2.5% |
| 2024 | $68.5 | $80.8 | +18% |
| 2025 | $80.8 | $78.0 | -3.5% |
| 2026 YTD | $78.0 | $75.0 | -3.8% |
SCI has finished higher in four of the last six years. It's down 3.8% so far in 2026.